Maine Statutes

§ 22 §1711-E — Confidentiality of prescription drug information

Maine·Title 22 HEALTH AND WELFARE·Part 4 HOSPITALS AND MEDICAL CARE·Ch. 401 GENERAL PROVISIONS
1.Definitions. As used in this section, unless the context otherwise indicates, the following terms have the following meanings. 1-A. Findings. 1-B. Purposes.
2.Confidentiality of prescription drug information that identifies the individual. A carrier or prescription drug information intermediary may not license, use, sell, transfer or exchange for value, for any marketing purpose, prescription drug information that identifies directly or indirectly the individual who is prescribed the prescription drug. 2-A. Confidentiality of prescription drug information that identifies the prescriber.
3.Enforcement. A violation of subsection 2 is a violation of the Maine Unfair Trade Practices Act.
4.Confidentiality protection procedures.
5.Rules. The department shall adopt rules to implement this

Free access — add to your briefcase to read the full text and ask questions with AI

Maine § 22 §1711-E (Confidentiality of prescription drug information) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

PL 2005, c. 589, §1 (NEW). PL 2007, c. 460, §1 (AMD). PL 2007, c. 695, Pt. C, §§6, 7 (AMD). PL 2011, c. 90, Pt. J, §10 (AMD). PL 2011, c. 443, §1 (AMD). PL 2011, c. 461, §1 (AMD). PL 2011, c. 494, §§1-6 (AMD). PL 2019, c. 469, §1 (AMD). PL 2019, c. 469, §9 (AFF).

Nearby Sections

8
View on official source ↗